South Korea · Delayed Price · Currency is KRW ALTEOGEN Statistics
Total Valuation
ALTEOGEN has a market cap or net worth of KRW 21.41 trillion. The enterprise value is 21.08 trillion.
| Market Cap | 21.41T |
| Enterprise Value | 21.08T |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
ALTEOGEN has 69.63 million shares outstanding. The number of shares has increased by 5.07% in one year.
| Current Share Class | 69.63M |
| Shares Outstanding | 69.63M |
| Shares Change (YoY) | +5.07% |
| Shares Change (QoQ) | -25.93% |
| Owned by Insiders (%) | 25.25% |
| Owned by Institutions (%) | 12.18% |
| Float | 52.05M |
Valuation Ratios
The trailing PE ratio is 113.08 and the forward PE ratio is 63.65.
| PE Ratio | 113.08 |
| Forward PE | 63.65 |
| PS Ratio | 84.29 |
| PB Ratio | 33.20 |
| P/TBV Ratio | 40.16 |
| P/FCF Ratio | 351.86 |
| P/OCF Ratio | 219.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 162.51, with an EV/FCF ratio of 346.41.
| EV / Earnings | 109.97 |
| EV / Sales | 82.99 |
| EV / EBITDA | 162.51 |
| EV / EBIT | 176.02 |
| EV / FCF | 346.41 |
Financial Position
The company has a current ratio of 5.73, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.73 |
| Quick Ratio | 5.10 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.12 |
| Interest Coverage | 8.80 |
Financial Efficiency
Return on equity (ROE) is 35.60% and return on invested capital (ROIC) is 59.05%.
| Return on Equity (ROE) | 35.60% |
| Return on Assets (ROA) | 11.15% |
| Return on Invested Capital (ROIC) | 59.05% |
| Return on Capital Employed (ROCE) | 18.46% |
| Weighted Average Cost of Capital (WACC) | 9.63% |
| Revenue Per Employee | 1.48B |
| Profits Per Employee | 1.11B |
| Employee Count | 172 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 11.18 |
Taxes
In the past 12 months, ALTEOGEN has paid 18.27 billion in taxes.
| Income Tax | 18.27B |
| Effective Tax Rate | 8.46% |
Stock Price Statistics
The stock price has decreased by -8.84% in the last 52 weeks. The beta is 0.97, so ALTEOGEN's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -8.84% |
| 50-Day Moving Average | 270,288.46 |
| 200-Day Moving Average | 304,085.58 |
| Relative Strength Index (RSI) | 54.20 |
| Average Volume (20 Days) | 586,107 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ALTEOGEN had revenue of KRW 254.01 billion and earned 191.70 billion in profits. Earnings per share was 2,719.40.
| Revenue | 254.01B |
| Gross Profit | 205.43B |
| Operating Income | 119.79B |
| Pretax Income | 216.06B |
| Net Income | 191.70B |
| EBITDA | 129.75B |
| EBIT | 119.79B |
| Earnings Per Share (EPS) | 2,719.40 |
Balance Sheet
The company has 446.84 billion in cash and 7.01 billion in debt, with a net cash position of 439.83 billion or 6,316.53 per share.
| Cash & Cash Equivalents | 446.84B |
| Total Debt | 7.01B |
| Net Cash | 439.83B |
| Net Cash Per Share | 6,316.53 |
| Equity (Book Value) | 644.98B |
| Book Value Per Share | 10,015.81 |
| Working Capital | 430.76B |
Cash Flow
In the last 12 months, operating cash flow was 97.69 billion and capital expenditures -36.84 billion, giving a free cash flow of 60.85 billion.
| Operating Cash Flow | 97.69B |
| Capital Expenditures | -36.84B |
| Depreciation & Amortization | 9.96B |
| Net Borrowing | -536.39M |
| Free Cash Flow | 60.85B |
| FCF Per Share | 873.93 |
Margins
Gross margin is 80.88%, with operating and profit margins of 47.16% and 75.47%.
| Gross Margin | 80.88% |
| Operating Margin | 47.16% |
| Pretax Margin | 85.06% |
| Profit Margin | 75.47% |
| EBITDA Margin | 51.08% |
| EBIT Margin | 47.16% |
| FCF Margin | 23.96% |
Dividends & Yields
This stock pays an annual dividend of 285.38, which amounts to a dividend yield of 0.10%.
| Dividend Per Share | 285.38 |
| Dividend Yield | 0.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 10.43% |
| Buyback Yield | -5.07% |
| Shareholder Yield | -4.97% |
| Earnings Yield | 0.90% |
| FCF Yield | 0.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for ALTEOGEN is 372,051.28, which is 23.61% higher than the current price. The consensus rating is "Buy".
| Price Target | 372,051.28 |
| Price Target Difference | 23.61% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 60.50% |
| EPS Growth Forecast (3Y) | 55.56% |
Stock Splits
The last stock split was on August 5, 2026. It was a forward split with a ratio of 1.3.
| Last Split Date | Aug 5, 2026 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
ALTEOGEN has an Altman Z-Score of 145.64 and a Piotroski F-Score of 7.
| Altman Z-Score | 145.64 |
| Piotroski F-Score | 7 |